Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Failure × maltodextrin × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3 Colonic Neoplasms 3 Rectal Neoplasms 1 Mucositis 1 Malnutrition 1 Liver Failure 1 Fibrosis 1 Diarrhea 1 Colonic Polyps 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1

Interventions

urinastatin 1 maltodextrin 1 halofantrine 1 Raltegravir Potassium 1 N-monoacetylcystine 1 Glycyrrhizic Acid 1 Everolimus 1 Blood Specimen Collection 1 Amino Acids 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03908255 2022-01-28

BCAA in HCC

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Withdrawn

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Failure, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon ⚡